EVIO OTC
EVIO, Inc.
1W: +0.0%
1M: -98.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±5196.4%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.0M
52W Range0.000001-0.0001
Volume49
Avg Volume3,044,522
Beta-2.39
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOLori Jean Glauser
Employees18
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2004-01-21
Websiteevioinc.com
2340 West Horizon Ridge Parkway
Henderson, NV 89052
US
Henderson, NV 89052
US
541 633 4568
About EVIO, Inc.
EVIO, Inc., along with its affiliates, provides specialized analytical testing and expert advisory services to the cannabis industry throughout the United States. The company's consulting expertise spans strategic guidance, product formulation assistance, and comprehensive support for licensing and regulatory compliance. Furthermore, EVIO conducts a full range of laboratory analyses, including cannabinoid potency assessment, terpene profiling, pesticide screening, residual solvent detection, visual inspections, and biological contaminant testing. The firm maintains its headquarters in Henderson, Nevada.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Smith Anthony R. | A-Award | 1,820,881 | $0.07 | 2020-01-31 |
| Waldrop William | A-Award | 3,029,007 | $0.07 | 2020-01-31 |
| GLAUSER LORI JEAN | A-Award | 2,503,650 | $0.07 | 2020-01-31 |
| GLAUSER LORI JEAN | P-Purchase | 7,000 | $0.31 | 2019-06-06 |
| GLAUSER LORI JEAN | P-Purchase | 6,000 | $0.55 | 2017-11-10 |